The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Potassium Gluconate Market Research Report 2024
Synopsis
Potassium gluconate is a mineral class drug that is specifically used to treat hypokalemia (a state in which potassium deficiency occurs in the blood stream). Potassium gluconate helps with the appropriate functioning of cells, kidney, heart, muscles, and nerves. Low potassium levels include weakness, fatigue, or weakening of reflexes; in this condition, the patient is treated with potassium gluconate drugs.
The global Potassium Gluconate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Potassium Gluconate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Potassium Gluconate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Potassium Gluconate include GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, AstraZeneca plc, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd. and Vectura Group plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Potassium Gluconate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Potassium Gluconate.
Report Scope
The Potassium Gluconate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Potassium Gluconate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Potassium Gluconate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Novartis AG
Merck & Co., Inc.
Abbott Laboratories
Boehringer Ingelheim GmbH
AstraZeneca plc
F. Hoffmann-La Roche AG
Teva Pharmaceutical Industries Ltd.
Vectura Group plc
Pfizer Inc.
Segment by Type
Oral
Parenteral
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Potassium Gluconate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Potassium Gluconate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Potassium gluconate is a mineral class drug that is specifically used to treat hypokalemia (a state in which potassium deficiency occurs in the blood stream). Potassium gluconate helps with the appropriate functioning of cells, kidney, heart, muscles, and nerves. Low potassium levels include weakness, fatigue, or weakening of reflexes; in this condition, the patient is treated with potassium gluconate drugs.
The global Potassium Gluconate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Potassium Gluconate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Potassium Gluconate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Potassium Gluconate include GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Abbott Laboratories, Boehringer Ingelheim GmbH, AstraZeneca plc, F. Hoffmann-La Roche AG, Teva Pharmaceutical Industries Ltd. and Vectura Group plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Potassium Gluconate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Potassium Gluconate.
Report Scope
The Potassium Gluconate market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Potassium Gluconate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Potassium Gluconate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline plc
Novartis AG
Merck & Co., Inc.
Abbott Laboratories
Boehringer Ingelheim GmbH
AstraZeneca plc
F. Hoffmann-La Roche AG
Teva Pharmaceutical Industries Ltd.
Vectura Group plc
Pfizer Inc.
Segment by Type
Oral
Parenteral
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Potassium Gluconate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Potassium Gluconate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Potassium Gluconate Market Overview
1.1 Product Overview and Scope of Potassium Gluconate
1.2 Potassium Gluconate Segment by Type
1.2.1 Global Potassium Gluconate Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Parenteral
1.3 Potassium Gluconate Segment by Application
1.3.1 Global Potassium Gluconate Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Potassium Gluconate Market Size Estimates and Forecasts
1.4.1 Global Potassium Gluconate Revenue 2019-2030
1.4.2 Global Potassium Gluconate Sales 2019-2030
1.4.3 Global Potassium Gluconate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Potassium Gluconate Market Competition by Manufacturers
2.1 Global Potassium Gluconate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Potassium Gluconate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Potassium Gluconate Average Price by Manufacturers (2019-2024)
2.4 Global Potassium Gluconate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Potassium Gluconate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Potassium Gluconate, Product Type & Application
2.7 Potassium Gluconate Market Competitive Situation and Trends
2.7.1 Potassium Gluconate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Potassium Gluconate Players Market Share by Revenue
2.7.3 Global Potassium Gluconate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Potassium Gluconate Retrospective Market Scenario by Region
3.1 Global Potassium Gluconate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Potassium Gluconate Global Potassium Gluconate Sales by Region: 2019-2030
3.2.1 Global Potassium Gluconate Sales by Region: 2019-2024
3.2.2 Global Potassium Gluconate Sales by Region: 2025-2030
3.3 Global Potassium Gluconate Global Potassium Gluconate Revenue by Region: 2019-2030
3.3.1 Global Potassium Gluconate Revenue by Region: 2019-2024
3.3.2 Global Potassium Gluconate Revenue by Region: 2025-2030
3.4 North America Potassium Gluconate Market Facts & Figures by Country
3.4.1 North America Potassium Gluconate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Potassium Gluconate Sales by Country (2019-2030)
3.4.3 North America Potassium Gluconate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Potassium Gluconate Market Facts & Figures by Country
3.5.1 Europe Potassium Gluconate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Potassium Gluconate Sales by Country (2019-2030)
3.5.3 Europe Potassium Gluconate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Potassium Gluconate Market Facts & Figures by Country
3.6.1 Asia Pacific Potassium Gluconate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Potassium Gluconate Sales by Country (2019-2030)
3.6.3 Asia Pacific Potassium Gluconate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Potassium Gluconate Market Facts & Figures by Country
3.7.1 Latin America Potassium Gluconate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Potassium Gluconate Sales by Country (2019-2030)
3.7.3 Latin America Potassium Gluconate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Potassium Gluconate Market Facts & Figures by Country
3.8.1 Middle East and Africa Potassium Gluconate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Potassium Gluconate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Potassium Gluconate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Potassium Gluconate Sales by Type (2019-2030)
4.1.1 Global Potassium Gluconate Sales by Type (2019-2024)
4.1.2 Global Potassium Gluconate Sales by Type (2025-2030)
4.1.3 Global Potassium Gluconate Sales Market Share by Type (2019-2030)
4.2 Global Potassium Gluconate Revenue by Type (2019-2030)
4.2.1 Global Potassium Gluconate Revenue by Type (2019-2024)
4.2.2 Global Potassium Gluconate Revenue by Type (2025-2030)
4.2.3 Global Potassium Gluconate Revenue Market Share by Type (2019-2030)
4.3 Global Potassium Gluconate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Potassium Gluconate Sales by Application (2019-2030)
5.1.1 Global Potassium Gluconate Sales by Application (2019-2024)
5.1.2 Global Potassium Gluconate Sales by Application (2025-2030)
5.1.3 Global Potassium Gluconate Sales Market Share by Application (2019-2030)
5.2 Global Potassium Gluconate Revenue by Application (2019-2030)
5.2.1 Global Potassium Gluconate Revenue by Application (2019-2024)
5.2.2 Global Potassium Gluconate Revenue by Application (2025-2030)
5.2.3 Global Potassium Gluconate Revenue Market Share by Application (2019-2030)
5.3 Global Potassium Gluconate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline plc
6.1.1 GlaxoSmithKline plc Corporation Information
6.1.2 GlaxoSmithKline plc Description and Business Overview
6.1.3 GlaxoSmithKline plc Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline plc Potassium Gluconate Product Portfolio
6.1.5 GlaxoSmithKline plc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis AG Potassium Gluconate Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck & Co., Inc. Potassium Gluconate Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Potassium Gluconate Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Boehringer Ingelheim GmbH
6.5.1 Boehringer Ingelheim GmbH Corporation Information
6.5.2 Boehringer Ingelheim GmbH Description and Business Overview
6.5.3 Boehringer Ingelheim GmbH Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boehringer Ingelheim GmbH Potassium Gluconate Product Portfolio
6.5.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Corporation Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca plc Potassium Gluconate Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 F. Hoffmann-La Roche AG
6.6.1 F. Hoffmann-La Roche AG Corporation Information
6.6.2 F. Hoffmann-La Roche AG Description and Business Overview
6.6.3 F. Hoffmann-La Roche AG Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche AG Potassium Gluconate Product Portfolio
6.7.5 F. Hoffmann-La Roche AG Recent Developments/Updates
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.8.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ltd. Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Teva Pharmaceutical Industries Ltd. Potassium Gluconate Product Portfolio
6.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.9 Vectura Group plc
6.9.1 Vectura Group plc Corporation Information
6.9.2 Vectura Group plc Description and Business Overview
6.9.3 Vectura Group plc Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Vectura Group plc Potassium Gluconate Product Portfolio
6.9.5 Vectura Group plc Recent Developments/Updates
6.10 Pfizer Inc.
6.10.1 Pfizer Inc. Corporation Information
6.10.2 Pfizer Inc. Description and Business Overview
6.10.3 Pfizer Inc. Potassium Gluconate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Pfizer Inc. Potassium Gluconate Product Portfolio
6.10.5 Pfizer Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Potassium Gluconate Industry Chain Analysis
7.2 Potassium Gluconate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Potassium Gluconate Production Mode & Process
7.4 Potassium Gluconate Sales and Marketing
7.4.1 Potassium Gluconate Sales Channels
7.4.2 Potassium Gluconate Distributors
7.5 Potassium Gluconate Customers
8 Potassium Gluconate Market Dynamics
8.1 Potassium Gluconate Industry Trends
8.2 Potassium Gluconate Market Drivers
8.3 Potassium Gluconate Market Challenges
8.4 Potassium Gluconate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
